Outrage over the cost of a pill. You might have seen the story this week: a former hedge fund manager buys the rights to a pill that can save lives, then raises the price 5000% overnight. Daraprim has been around for 62 years, treating malaria and toxoplasmosis; AIDS patients in particular can benefit from the drug. When a company called Turing acquired the drug, the price jumped from $13.50 per pill to $750. Turing's CEO said that this is the cost of doing research, which could lead to better drugs. Critics have called this the worst kind of price gouging. Our panel discusses it:
- Dr. William Valenti, Trillium Health vice president and lead physician
- Dr. Jonathan Hager, primary care physician
- Jane Dodds, Practice Administrator with Women Gynecology & Childbirth Associates, and a member of the Board of the New York State Medical Group Management Association
